Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic  Jeffrey R. Winterfield, MD, FHRS, David.

Published byClaude Pépin Modified over 5 years ago

Similar presentations

Presentation on theme: "Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic  Jeffrey R. Winterfield, MD, FHRS, David."— Presentation transcript:

1 Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic  Jeffrey R. Winterfield, MD, FHRS, David J. Milan, MD  HeartRhythm Case Reports  Volume 2, Issue 4, Pages (July 2016) DOI: /j.hrcr Copyright © 2016 Heart Rhythm Society Terms and Conditions

2 Figure 1 A: A baseline electrocardiogram, recorded at presentation, with QTc prolongation measuring ~508 milliseconds prior to administration of arsenic or other potential QT-prolonging agents. B: An electrocardiogram recorded June 29, 2013, after dexamethasone reduces QTc. Dexamethasone had been administered for nausea, and we observed QTc reduction to ~478 milliseconds. HeartRhythm Case Reports 2016 2, DOI: ( /j.hrcr ) Copyright © 2016 Heart Rhythm Society Terms and Conditions

3 Figure 2 A: Marked correct QT (QTc) prolongation to 581 milliseconds during the first cycle of consolidation chemotherapy with arsenic, which resulted in therapy discontinuation and inpatient admission for monitoring. The QTc returned to baseline following the cessation of arsenic treatment. B: Rescue of arsenic-triggered QTc prolongation with dexamethasone. QTc measurements (blue bars indicate measurement points) during arsenic administration before and after administration of high-dose dexamethasone. HeartRhythm Case Reports 2016 2, DOI: ( /j.hrcr ) Copyright © 2016 Heart Rhythm Society Terms and Conditions

4 Figure 3 Corrected QT (QTc) measurements during treatment with arsenic and dexamethasone. Temporal declines in QTc correlated with cessation of arsenic therapy and also with dexamethasone treatment. HeartRhythm Case Reports 2016 2, DOI: ( /j.hrcr ) Copyright © 2016 Heart Rhythm Society Terms and Conditions

Download ppt "Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic  Jeffrey R. Winterfield, MD, FHRS, David."

Similar presentations

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.
Ventricular tachycardia in iron man

Ventricular tachycardia in iron man
Acquired Long QT Syndrome and Monomorphic Ventricular Tachycardia After Alternative Treatment With Cesium Chloride for Brain Cancer  Anuj K. Dalal, MD,

Acquired Long QT Syndrome and Monomorphic Ventricular Tachycardia After Alternative Treatment With Cesium Chloride for Brain Cancer  Anuj K. Dalal, MD,
Sinus bradycardia and chronotropic incompetence associated with single-agent itraconazole antifungal therapy: A case report  Julian Tokarev, BS, David.

Sinus bradycardia and chronotropic incompetence associated with single-agent itraconazole antifungal therapy: A case report  Julian Tokarev, BS, David.
Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation  Brian J. Cross, MD, Mark S. Link, MD, FHRS 

Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation  Brian J. Cross, MD, Mark S. Link, MD, FHRS 
A subtype of idiopathic ventricular fibrillation and its relevance to catheter ablation and genetic variants  Takahiko Nishiyama, MD, Yoshiyasu Aizawa,

A subtype of idiopathic ventricular fibrillation and its relevance to catheter ablation and genetic variants  Takahiko Nishiyama, MD, Yoshiyasu Aizawa,
Recurrent commotio cordis: Déjà vu

Recurrent commotio cordis: Déjà vu
A 35-year effective treatment of catecholaminergic polymorphic ventricular tachycardia with propafenone  Alexandra Marx, MD, Björn Lange, MD, Carsten.

A 35-year effective treatment of catecholaminergic polymorphic ventricular tachycardia with propafenone  Alexandra Marx, MD, Björn Lange, MD, Carsten.
A case of paroxysmal atrioventricular block–induced cardiac arrest

A case of paroxysmal atrioventricular block–induced cardiac arrest
Left ventricle penetration—A rare complication of transseptal puncture and catheter ablation for supraventricular tachycardia  Nelson Chavarria, MD, Seth.

Left ventricle penetration—A rare complication of transseptal puncture and catheter ablation for supraventricular tachycardia  Nelson Chavarria, MD, Seth.
Drug-induced acute pneumonitis following initiation of flecainide therapy after pulmonary vein isolation ablation in a patient with mitral stenosis and.

Drug-induced acute pneumonitis following initiation of flecainide therapy after pulmonary vein isolation ablation in a patient with mitral stenosis and.
Unusual case of late dislodgment of a superior vena cava coil

Unusual case of late dislodgment of a superior vena cava coil
Is it bradycardia or something else causing symptoms?

Is it bradycardia or something else causing symptoms?
Normalization of QT interval duration in a long QT syndrome patient during pregnancy and the postpartum period due to sex hormone effects on cardiac repolarization 

Normalization of QT interval duration in a long QT syndrome patient during pregnancy and the postpartum period due to sex hormone effects on cardiac repolarization 
Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.

Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.
HeartRhythm Case Reports

HeartRhythm Case Reports
Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient  Isla McClelland, MD,

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient  Isla McClelland, MD,
Santiago O. Valdés, MD, Andrew P. Landstrom, MD, PhD, Andrew E

Santiago O. Valdés, MD, Andrew P. Landstrom, MD, PhD, Andrew E
Darren C. Tsang, BS, Roger G. Carrillo, MD, MBA, FHRS 

Darren C. Tsang, BS, Roger G. Carrillo, MD, MBA, FHRS 
Increased threshold in nonselective His-bundle pacing suspected to be caused by amiodarone  JoonHyuk Kim, MD, Seth Goldbarg, MD, FHRS, Steven Leung, MD,

Increased threshold in nonselective His-bundle pacing suspected to be caused by amiodarone  JoonHyuk Kim, MD, Seth Goldbarg, MD, FHRS, Steven Leung, MD,

Similar presentations

Ads by Google